| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1616983-07-3 | 4,6-Dibromobenzene-1,2,3,5-d4 | C6D4Br2 |
| 1618083-32-1 | 3-Amino-4-(aminomethyl)benzoic acid methyl ester | C9H12N2O2 |
| 1618107-00-8 | 2-Chloro-4-(2-dibenzofuranyl)-6-phenyl-1,3,5-triazine | C21H12ClN3O |
| 1618657-31-0 | Ezetimibe Impurity 9 | C18H17FO4 |
| 1619934-76-7 | Ethyl 1-(4-methoxyphenyl)-7a-morpholino-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-3a,4,5,6,7,7a-hexahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C31H37N5O6 |
| 1619967-09-7 | (3,3'-Difluoro-[2,2'-bithiophene]-5,5'-diyl)bis(trimethylstannane) | C14H20F2S2Sn2 |
| 1619994-68-1 | 1-[1-[2-(Methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]ethanone | C20H21NO4S |
| 1619994-69-2 | Ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate | C17H20N6O4S |
| 1620056-83-8 | 2-(5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic acid | C10H7F5N2O2 |
| 1620097-04-2 | N-[(3R)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-1-oxobutyl]-N-(phenylmethyl)glycine methyl ester | C19H28N2O5 |
| 1620097-05-3 | (7R)-Tetrahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepine-2,5-dione | C13H16N2O2 |
| 1620097-06-4 | (5R)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine | C13H20N2 |
| 1620097-07-5 | [(7R)-Hexahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone | C23H27N5O |
| 1620146-04-4 | 2-(Acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1$rarr$4)-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1$rarr$2)]-O-beta-D-mannopyranosyl-(1$rarr$4)-O-[O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1$rarr$4)-O-[O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1$rarr$2)]-O-alpha-D-mannopyranosyl-(1$rarr$3)]-O-alpha-D-mannopyranosyl-(1$rarr$4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1$rarr$4)-D-mannose | C66H110N6O46 |
| 1620222-02-7 | 2,3:5,6-Bis-O-(1-methylethylidene)-D-myo-inositol 1,4-dibutanoate | C20H32O8 |
| 1620389-14-1 | L-Phenylalanyl-L-leucyl-L-leucylglycyl-L-leucyl-L-isoleucyl-L-phenylalanyl-L-leucyl-L-leucine | C56H89N9O10 |
| 1620401-82-2 | 6,7-Dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-4-quinazolinamine | C23H35N5O2 |
| 1620410-09-4 | Pyrazine-2,3-diyldimethanethiol | C6H8N2S2 |
| 1620458-09-4 | Zoliflodacin | C22H22FN5O7 |
| 1620576-64-8 | 1-[4-[5-[5-Amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-ethyl-1H-1,2,4-triazol-3-yl]piperidin-1-yl]-3-hydroxypropan-1-one | C22H31N9O3 |
| 1620758-21-5 | Empagliflozin Impurity 6 | C32H37ClO12 |
| 1620758-27-1 | (S)-Empagliflozin Peracetyl | C31H35ClO11 |
| 1620758-31-7 | (1R)-1,4-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol | C23H27ClO7 |
| 1620758-32-8 | (1S)-1,4-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol | C23H27ClO7 |
| 1620758-33-9 | (1R)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol | C23H27ClO7 |
| 1620758-34-0 | (1R)-1-C-[4-Chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol | C23H29ClO8 |
| 1620823-61-1 | Rosuvastatin EP Impurity C Sodium Salt | C22H25FN3O6S .Na |
| 1620905-72-7 | 1-(6-Amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxy-1-azetidinyl)-4-oxo-3-quinolinecarboxylic acid ethyl ester | C20H16ClF3N4O4 |
| 1620989-13-0 | 3-Amino-2-ethylphenol | C8H11NO |
| 1621066-74-7 | (1S)-6,6'-Dibromo-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol | C17H14Br2O2 |
| 1621085-33-3 | 3-Methyl-N-[(phenylmethoxy)carbonyl]-L-valine compd. with 2-propanamine | C14H19NO4.C3H9N |
| 1621175-65-2 | N-[3-Chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide | C18H19ClN6O2S |
| 1621182-18-0 | 6-Nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4(3H)-quinazolinone | C12H11N3O5 |
| 1621274-11-0 | (SP-4-3)-(methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC][tris(1,1-dimethylethyl)phosphine]-Palladium | C26H42NO3PPdS |
| 1621274-13-2 | (SP-4-3)-[2'-(Dicyclohexylphosphino)-N,N-dimethyl[1,1'-biphenyl]-2-amine](methanesulfonato)[2'-(methylamino)[1,1'-biphenyl]-2-yl]palladium | C40H51N2O3PPdS |
| 1621274-17-6 | DPPF Pd G4 | C48H43FeNO3P2PdS |
| 1621274-19-8 | (SP-4-3)-[[5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]diphenylphosphine-κP](methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]-Palladium | C53H47NO4P2PdS |
| 1621681-63-7 | Cabozantinib N-oxide | C28H24FN3O6 |
| 1622008-73-4 | 4,4'-(2,3-Dihydrothieno[3,4-b]-1,4-dioxin-5,7-diyl)bis[N,N-bis(4-methoxyphenyl)-benzenamine] | C46H40N2O6S |
| 1622173-72-1 | Cinacalcet Impurity 50 HCl | C22H25ClF3N |
| 1622303-52-9 | 4-Bromo-6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid | C9H7BrN2O3 |
| 1622848-92-3 | (S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide | C20H19N5O3 |
| 1622849-58-4 | 5-(Phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-isoxazolecarboxamide | C21H19N3O4 |
| 1622902-68-4 | N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide | C14H21N5O2S |
| 1622921-15-6 | 4-[2-(2-Cyclopentylidenehydrazinyl)-4-thiazolyl]benzonitrile hydrobromide | C15H14N4S.HBr |
| 1622928-68-0 | 1-Methoxy-4-oxocyclohexane-1-carboxylic acid | C8H12O4 |
| 1622928-69-1 | Cyclohexanecarboxylic acid, 1-methoxy-4-oxo-, phenylmethyl ester | C15H18O4 |
| 1622945-04-3 | 1-(2-Pyridinyl)ethanone 2-(4a,5-dihydro-6-methyl-2H-1,2,4-triazino[5,6-b]indol-3-yl)hydrazone | C17H17N7 |
| 1623101-11-0 | 3-Chloro-N-[3-chloro-4-(4-chloro-1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]-2-pyridinecarboxamide | C20H10Cl3N3O3 |
| 1623109-09-0 | 3-[4-(Trifluoromethoxy)phenyl]-1,2,4-oxadiazole-5-carboxylic acid 2-(1-iminoethyl)hydrazide | C12H10F3N5O3 |